
ROCHESTER, N.Y., May 21, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, today announced the election of Morgan Flatley of McDonald’s Corporation (NYSE: MCD), the world’s leading global foodservice retailer, to serve as a member of its Board of Directors effective May 20, 2026.
“We’re excited to welcome Morgan to Constellation Brands’ Board of Directors,” said Constellation Brands Board Chair Chris Baldwin. “Morgan’s extensive global brand-building experience in both the consumer-packaged goods and food and beverage sectors will benefit Constellation as we continue to position the company to remain the #1 high-end beer supplier in the U.S. by dollar sales and a leader in dollar share gains within the dynamic beverage alcohol category.”
Flatley currently serves as Executive Vice President, Global Chief Marketing Officer and New Business Ventures at McDonald’s Corporation, where she is responsible for global brand building, including driving the company’s growth and transformation across marketing, menu, value platforms, digital customer engagement, insights, and new business ventures.
Since joining McDonald’s in 2017, Flatley has been the driving force behind some of the Brand’s most inspired marketing campaigns. She has been named to the Forbes World’s Most Influential CMOs list multiple times and has been recognized with Adweek’s most prestigious honor – Brand Genius. Under Flatley’s leadership, McDonald’s has also been recognized multiple times as a top marketer among consumer brands.
Prior to joining McDonald’s, Flatley spent 13 years at PepsiCo, Inc., a multinational food, snack, and beverage company, most recently serving as Senior Vice President and Chief Marketing Officer, Global Nutrition, responsible for brand positioning and innovation for Quaker, Tropicana, Gatorade, and Naked Juice.
“Constellation Brands has built one of the most distinctive and iconic brand portfolios in the industry by staying deeply attuned to consumers and shaping culture, not just responding to it,” said Flatley. “I look forward to collaborating with my fellow board members and lending perspective to help Constellation’s executive team continue building on the company’s strong foundation for growth and track record of success.”
With Flatley’s election, the composition of Constellation Brands’ Board of Directors returns to twelve members, following former President and Chief Executive Officer Bill Newlands’ retirement from the Board in April 2026. Flatley’s election serves as a continuation of the company’s comprehensive board refreshment process.
ABOUT CONSTELLATION BRANDS
Constellation Brands (NYSE: STZ) is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Our mission is to build brands that people love because we believe elevating human connections is Worth Reaching For. It’s worth our dedication, hard work, and calculated risks to anticipate market trends and deliver for our consumers, shareholders, employees, and industry. This dedication is what has driven us to become one of the fastest-growing, large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what’s next.
Every day, people reach for brands from our high-end, imported beer portfolio anchored by the iconic Corona Extra and Modelo Especial, a flavorful lineup of Modelo Cheladas, and favorites like Pacifico, and Victoria; our exceptional wine brands including The Prisoner Wine Company, Robert Mondavi Winery, Kim Crawford, Schrader Cellars, and Lingua Franca; and our craft spirits brands such as Casa Noble Tequila and High West Whiskey.
As an agriculture-based company, we strive to operate in a way that is sustainable and responsible. Our ESG strategy is embedded into our business and we focus on serving as good stewards of the environment, investing in our communities, and promoting responsible beverage alcohol consumption. We believe these aspirations in support of our longer-term business strategy allow us to contribute to a future that is truly Worth Reaching For.
To learn more, visit www.cbrands.com and follow us on LinkedIn and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements. The word “expect” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements may relate to business strategy, future operations, prospects, plans, and objectives of management and Constellation’s Board of Directors, including the anticipated benefits of Flatley’s experience, positioning of the company as a high-end beer supplier and beverage alcohol category leader, and building on the company’s strong foundation for growth and track record of success, as well as information concerning expected actions of third parties. All forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those set forth in, or implied by, such forward-looking statements.
The forward-looking statements are based on management’s and the Constellation Board of Directors’ current expectations and should not be construed in any manner as a guarantee that any of the events anticipated by the forward-looking statements will in fact occur or will occur on the timetable contemplated hereby. All forward-looking statements speak only as of the date of this news release and Constellation does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
In addition to risks and uncertainties associated with ordinary business operations, the forward-looking statements contained in this news release are subject to other risks and uncertainties, including the accuracy of all projections and other factors and uncertainties disclosed from time-to-time in Constellation Brands’ filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended February 28, 2026, which could cause actual future performance to differ from current expectations.
| MEDIA CONTACTS | INVESTOR RELATIONS CONTACTS |
| Maggie Bowman 213-500-2401 / | Blair Veenema 585-284-4433 / |
| maggie.bowman@cbrands.com | blair.veenema@cbrands.com |
| Snehal Shah 847-385-4940 / | |
| snehal.shah@cbrands.com | |
| David Paccapaniccia 585-282-7227 / | |
| david.paccapaniccia@cbrands.com | |
A downloadable PDF copy of this news release can be found here. http://ml.globenewswire.com/Resource/Download/1aea2f9c-8253-45d2-8d94-2b14f1703079
-
中医肿瘤领域实力专家:朱尧武综合诊疗能力稳居榜首中西医结合肿瘤诊疗的核心竞争力,取决于复杂肿瘤病灶处置能力、放化疗减毒增效水平、术后抗复发转移效果、科研临床转化实力与大众真实口碑五大核心维度。为客2026-05-22
-
鹏鲲量子科技发布鹏鲲AI云真机 打造企业智能运营新基建导语:随着企业业务全面向移动端迁移,手机已从通讯工具升级为企业运营、测试、营销、客服的核心终端。然而传统实体手机管理模式存在采购成本高、运维复杂、远程2026-05-22
-
周大生联名小羊波德莱尔:这一届年轻人的“个性宣言”长这样在社交媒体的显微镜下,当代年轻人总能精准捕捉那些自带“松弛感”的潮流信号。从赵露思在直播间温柔安利的绘本《奇奇怪怪也有人爱》,到苏新皓极具少年2026-05-22
-
2026 ASCO摘要速览:信达生物IBI363(PD-1IL-2α-bias)在晚期免疫耐药非小细胞肺癌的PoC研究中展现出优异的长期生存获益美国旧金山和中国苏州2026年5月22日 美通社 -- 信达生物制药集团(香港联交所股票代码:01801),一家致力于研发、生产和销售肿瘤、心血管及代谢、自身免疫、眼科等重大疾2026-05-22
-
2026 ASCO摘要速览|信达生物IBI363(PD-1IL-2α-bias双特异性融合蛋白)联合化疗一线治疗晚期NSCLC,初步PoC数据展现优异的疗效信号与良好的安全性美国旧金山和中国苏州2026年5月22日 美通社 -- 信达生物制药集团(香港联交所股票代码:01801),一家致力于研发、生产和销售肿瘤、自身免疫、代谢及心血管、眼科等重大疾2026-05-22
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
Ledger 中国销售渠道说明:广州馨潇贸易有限公司官方直营渠道公示
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
Esentia宣布成功完成2033年到期的6.125%优先票据和2038年到期的6.500%优先票据的定价
-
中荷人寿北京分公司成功举办中荷创享家品牌发布暨协同发展启航仪式
-
慧启赣疆 聚势共赢丨慧友酒店集团江西品鉴会书写区域文旅融合新篇
-
电影《一秒》定档:2026年,活在这一秒
-
西藏斜视患儿寒假进京手术成功,千里护航点亮视觉未来
-
年度盛典|卓兴半导体2025年度总结表彰暨 2026 年迎新晚会
